Protein A adsorption of acute myelogenous leukemia serum induces in vitro blast lysis

7Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

We studied cytotoxic activity of acute myelogenous leukemia (AML) sera for AML blasts before and after immunoadsorption with Staphylococcus aureus, Cowan I (SAC), which contains protein A. We found in vitro that incubation with treated AML sera reduced viability to 42.7% of control (p < 0.01) for autologous and 21.0% of control (p < 0.01) for allogeneic blasts. Normal peripheral blood cells were not killed by treated AML sera. Wood 46 strain of Staphylococcus aureus, which does not contain protein A, did not significantly reduce AML blast viability (94.8%, p > 0.4), while Sepharose-bound protein A reduced viability to 63.8% (p < 0.01). Cytotoxicity does not appear to be complement-mediated, byt cytotoxic activity is trypsin-sensitive and is contained in the immunoglobulin fraction. This model for study of the tumoricidal action of protein A adsorption should be useful for predicting utility of plasma adsorption as a therapeutic adjunct in the future.

Cite

CITATION STYLE

APA

Miller, W. J., Branda, R. F., Hurd, D. D., Wachsman, W., Nelson, N. L., & Jacob, H. S. (1982). Protein A adsorption of acute myelogenous leukemia serum induces in vitro blast lysis. Blood, 59(6), 1344–1347. https://doi.org/10.1182/blood.v59.6.1344.bloodjournal5961344

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free